Acta oto-laryngologica · 2009
Intranasal Capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ciabatti Pier Guido, D'Ascanio Luca
Аннотация
CONCLUSION: Local Capsicum oleous nasal spray, 4 microg/puff three times a day for 3 consecutive days, is an efficacious and safe treatment for idiopathic rhinitis (IR). Furthermore, being a natural product, Capsicum oleous nasal spray may be readily available for patients.
OBJECTIVES: To evaluate the efficacy and safety of different therapeutic regimens of Capsicum oleous nasal spray in IR.
PATIENTS AND METHODS: A total of 208 patients affected by IR were enrolled in a randomized placebo-controlled trial. Diagnosis of IR was made on the basis of history of nasal obstruction, sneezing and/or rhinorrhoea and after exclusion of other nasal/paranasal anatomic disorders. IR patients were randomized into four groups (groups A, B, and C) receiving increasing doses of Capsicum (1, 2 or 4 microg/puff, respectively) and one group (group D) treated with placebo. Capsicum oleous nasal spray, one puff per nostril, was instilled three times a day at 30 min intervals for 3 consecutive days. Pre- and post-treatment nasal symptoms were evaluated with a daily record chart.
RESULTS: A significant reduction in the frequency of IR symptom was noticed in group C (4 microg/puff, three times a day for 3 consecutive days) vs controls (p=0.003). No significant difference in side effects was recorded in patients receiving Capsicum therapy with respect to controls.
OBJECTIVES: To evaluate the efficacy and safety of different therapeutic regimens of Capsicum oleous nasal spray in IR.
PATIENTS AND METHODS: A total of 208 patients affected by IR were enrolled in a randomized placebo-controlled trial. Diagnosis of IR was made on the basis of history of nasal obstruction, sneezing and/or rhinorrhoea and after exclusion of other nasal/paranasal anatomic disorders. IR patients were randomized into four groups (groups A, B, and C) receiving increasing doses of Capsicum (1, 2 or 4 microg/puff, respectively) and one group (group D) treated with placebo. Capsicum oleous nasal spray, one puff per nostril, was instilled three times a day at 30 min intervals for 3 consecutive days. Pre- and post-treatment nasal symptoms were evaluated with a daily record chart.
RESULTS: A significant reduction in the frequency of IR symptom was noticed in group C (4 microg/puff, three times a day for 3 consecutive days) vs controls (p=0.003). No significant difference in side effects was recorded in patients receiving Capsicum therapy with respect to controls.